SynthesisJournal of affective disorders2026
Examining photoperiod, chronotype, and adherence as predictors of morning light treatment effects on depression symptoms: A study of five clinical trials.
Synthesis in Journal of affective disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Bright Light Treatment At Home To Manage Chronic Pain In U.S. Veterans
Morning Light Treatment at Home to Reduce PTSD Symptoms
Bright Light Treatment at Home to Improve Symptom Management of Fibromyalgia Syndrome
Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Morning light treatment (MLT) is increasingly being evaluated for a variety of health conditions; therefore, it is important to consider factors that may impact MLT outcomes. Natural light availability, chronotype, and treatment adherence have been posited to affect MLT. However, no prior studies have directly tested light availability and adherence as predictors of MLT outcomes and studies examining chronotype yielded mixed results. We aggregated data from five clinical trials of MLT (N = 86) for multiple conditions: probable posttraumatic stress disorder (NCT03513848), traumatic stress (NCT04117347), fibromyalgia (NCT03794908), human immunodeficiency virus, and chronic low back pain (NCT02373189). Depression symptoms are highly comorbid with all of these conditions; therefore, we examined whether light availability (season/photoperiod at MLT initiation), chronotype (self-reported morningness-eveningness and average bedtime prior to treatment), and objectively-measured MLT adherence predicted depression symptom change over time. All participants completed 60-min of daily MLT at home for 2 or 4 weeks using a light box or wearable device. We conducted a series of multilevel models nested by individual across time and study cohort. Depression symptoms improved across all trials. Later bedtime was a moderate but non-significant predictor of depression symptom improvement, providing preliminary evidence that later chronotypes may have better responses to MLT. Season and photoperiod were weak and non-significant predictors of depression symptom improvement, suggesting individuals may benefit from MLT throughout the year. Adherence also did not predict depression improvement, but these results should be interpreted with caution given that adherence was high and closely monitored in all trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.